Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna COVID-19 vaccine approved for six- to 11-year-old children

Children aged six to 11 years can get a Moderna COVID-19 vaccine from tomorrow, after it was given the final green light.

ABC News

Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends Australians aged 16 years and older have a COVID booster vaccine three months after receiving their second dose.

The Conversation

Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline

Moderna Inc (NASDAQ: MRNA) said it is deve

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

How trying to copy a COVID vaccine changes the outlook for African countries

The World Health Organisation (WHO) has announced the first six African countries that will receive technology to produce messenger RNA (mRNA) vaccines. This comes off the back of the news that a South African consortium – part of the WHO’s technology transfer hub set up in 2021– had successfully replicated…

The Conversation

Six African Countries to Receive mRNA Vaccine Technology

The first African countries selected to receive the technology necessary to produce mRNA vaccines against COVID-19 are Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia, a summit meeting of European Union and African Union nations heard on Friday. The six countries have been chosen to build vaccine production factories as…

Asharq Al-Awsat

Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters

Moderna Inc's (NASDAQ: MRNA) CEO, Stephane Bancel, told Reuters that an

Benzinga

This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart

Macy's Inc (NYSE: M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Covid booster will be needed in autumn, says Moderna chief executive Stephane Bancel

Another Covid booster vaccine will be needed by autumn, the chief executive of Moderna has said.

Evening Standard

Germany and Portugal to cut restrictions – as it happened

Germany and Portugal preparing to axe most curbs as cases stabilise; Israel’s PM says ‘green pass’ system to be suspended as cases decline

The Guardian - UK

TGA approves Moderna COVID-19 vaccine for children aged six and older

The Therapeutic Goods Administration approves the Moderna vaccine for children aged six and older.

ABC News

Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs

Spain's Laboratorios Farmaceuticos Rovi SA has agreed on a 10-year extension

Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Covid-19: Omicron-specific vaccine trials launched in UK as volunteers needed

The trials will include 3,000 participants in 13 locations including some in Scotland.

Daily Record

Thousands of volunteers sought for Moderna Omicron booster vaccine study

The study will see half the volunteers receive the new Moderna Omicron variant vaccine, and the other half vaccinated with the regular Moderna jab

Chronicle Live

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Germany and Switzerland set to ease restrictions – as it happened

This blog is now closed.

Wales Online

Moderna seeks volunteers for Omicron booster vaccine study

UK volunteers needed to take part in trials

The Conversation

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

Benzinga

Moderna Continues To See Bearish Movement: What's Next For The COVID-19 Stock?

Moderna Inc. (NASDAQ: MRNA) shares are trading lower Monday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know

Moderna Inc (NASDAQ: MRNA) shares are down more than 40% since the start of the year and continue to trend lower Monday.

The Guardian - AU

Coronavirus live: UK records 41,648 new cases and 35 Covid-linked deaths; French protest convoy reaches Brussels – as it happened

UK cases down 30% on the previous week, with weekly deaths down 27.2%; 500 French vehicles arrive in Brussels to protest against Covid measures

The Independent UK

How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?

Booster jabs provide up to 70 per cent protection, study finds

Pedestrian.tv

We’ve Officially Got A Fourth Vaccine, So Here’s Everything You Need To Know About Novavax

Say hello to Ms Novavax!

Ballotpedia

Hawaii, New York enact new congressional district maps; Pennsylvania Supreme Court assumes control over redistricting

Our weekly summary of federal news highlights redistricting updates in Hawaii, New York, and Pennsylvania, and the FDA approving the Moderna COVID-19 vaccine. Read all about it in this week’s edition of the Federal Tap.

Tribune News Service

Moderna’s COVID-19 vaccine gets backing from CDC advisory panel

Moderna Inc.’s COVID-19 shot received unanimous backing from a group of key U.S. health advisers after its approval, a move that could help encourage the hesitant to get vaccinated as the omicron variant continues to spread across the country.

Salon

At last, HIV vaccine in phase one trials

Years of false starts have made hopeful researchers wary of claims that an HIV vaccine is finally here

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

World Health Organisation

267 stories

MRNA

215 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.